Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-02

Clinical Trial Update: Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase III clinical trial update for Benvitimod Cream in mild to moderate atopic dermatitis is reported but status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benvitimod Cream (benvimod)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Atopic Dermatitis | Phase 3 | Status: UNKNOWN